Clostridioides difficile infection: A systematic review and meta-analysis of randomized controlled trials. J Infect Chemother. 2022 Nov;28(11):1536-1545. 9. Shoji K, Saito J, Nakamura H, Matsumoto K, Oda K, Takesue Y, Miyairi I. Current Aspects of Pediatric Pharmacokinetics and Pharmacodynamics of Antimicrobials in Japan: Importance of the Promotion of Population PK/PD Analysis. Pediatr Infect Dis J. 2022 Oct 1;41(10):e418-e423. 10. Hasegawa T, Tashiro S, Mihara T, Kon J, Sakurai K, Tanaka Y, Morita T, Enoki Y, Taguchi K, Matsumoto K, Nakajima K, Takesue Y. Efficacy of surgical skin preparation with chlorhexidine in alcohol according to the concentration required to prevent surgical site infection: meta-analysis. BJS Open. 2022 Sep 2;6(5):zrac111. 11. Suzuki Y, Taguchi K, Okamoto W, Enoki Y, Komatsu T, Matsumoto K. Methemoglobin-albumin clusters for the treatment of hydrogen sulfide intoxication. J Control Release. 2022 Sep;349:304-314. 12. Suzuki Y, Taguchi K, Kure T, Enoki Y, Otagiri M, Sakai H, Matsumoto K. Liposomal methemoglobin as a potent antidote for hydrogen sulfide poisoning. Toxicol Appl Pharmacol. 2022 Sep 1;450:116159. 13. Ichinose N, Shinoda K, Yoshikawa G, Fukao E, Enoki Y, Taguchi K, Oda T, Tsutsumi K, Matsumoto K. Exploring the Factors Affecting the Transferability of Vancomycin to Cerebrospinal Fluid in Postoperative Neurosurgical Patients with Bacterial Meningitis. Biol Pharm Bull. 2022;45(9):1398-1402. 14. Hanaya K, Yamoto K, Taguchi K, Matsumoto K, Higashibayashi S, Sugai T. Single-Step N-Terminal Modification of Proteins via a Bio-Inspired Copper(II)-Mediated Aldol Reaction. Chemistry. 2022 Aug 22;28(47):e202201677. 15. Kunishima H, Ohge H, Suzuki H, Nakamura A, Matsumoto K, Mikamo H, Mori N, Morinaga Y, Yanagihara K, Yamagishi Y, Yoshizawa S. Japanese Clinical Practice Guidelines for Management of Clostridioides (Clostridium) difficile infection. J Infect Chemother. 2022 Aug;28(8):1045-1083. 16. Ito C, Taguchi K, Moroi Y, Enoki Y, Tokuda R, Yamasaki K, Imoto S, Matsumoto K. Trimethoxy Trityl Groups as a Potent Substituent for Anti-cancer Cytidine Analog Prodrugs. J Pharm Sci. 2022 Aug;111(8):2201-2209. 17. Ichinose N, Yoshikawa G, Fukao E, Takahata T, Ichisawa M, Enoki Y, Taguchi K, Oda T, Tsutsumi K, Matsumoto K. Influences of protein levels on the cerebrospinal fluid distribution of ceftazidime & ceftriaxone in the cerebrospinal fluid of patients with inflamed meningitis. J Infect Chemother. 2022 Aug;28(8):1216-1219. 18. Umezaki Y, Matsumoto K, Ikawa K, Yokoyama Y, Enoki Y, Shigemi A, Watanabe E, Nakamura K, Ueno K, Terazono H, Morikawa N, Takeda Y. Concentration-Dependent Activity of Pazufloxacin against Pseudomonas aeruginosa: An In Vivo Pharmacokinetic/Pharmacodynamic Study. Antibiotics (Basel). 2022 Jul 21;11(7):982. 19. Gotoda M, Enoki Y, Shishido S, Taguchi K, Matsumoto K. Neurotoxicity associated with colistin methanesulfonate treatment is enhanced by concomitant sevoflurane inhalation. Toxicol Rep. 2022 Jun 2;9:1255-1260. 20. Ozawa T, Namkoong H, Takaya R, Takahashi Y, Fukunaga K, Enoki Y, Taguchi K, Kizu J, Matsumoto K, Hasegawa N. Analysis of adverse drug events in pulmonary Mycobacterium avium complex disease using spontaneous reporting system. BMC Infect Dis. 2022 Jun 29;22(1):580. 薬効解析学講座 11 薬効解析学講座 147
元のページ ../index.html#151